183 related articles for article (PubMed ID: 19332323)
1. Neuropeptide Y overexpression using recombinant adeno-associated viral vectors.
Noé F; Frasca A; Balducci C; Carli M; Sperk G; Ferraguti F; Pitkänen A; Bland R; Fitzsimons H; During M; Vezzani A
Neurotherapeutics; 2009 Apr; 6(2):300-6. PubMed ID: 19332323
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in epilepsy: the focus on NPY.
Noe' F; Nissinen J; Pitkänen A; Gobbi M; Sperk G; During M; Vezzani A
Peptides; 2007 Feb; 28(2):377-83. PubMed ID: 17196301
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus.
Richichi C; Lin EJ; Stefanin D; Colella D; Ravizza T; Grignaschi G; Veglianese P; Sperk G; During MJ; Vezzani A
J Neurosci; 2004 Mar; 24(12):3051-9. PubMed ID: 15044544
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.
Noè F; Pool AH; Nissinen J; Gobbi M; Bland R; Rizzi M; Balducci C; Ferraguti F; Sperk G; During MJ; Pitkänen A; Vezzani A
Brain; 2008 Jun; 131(Pt 6):1506-15. PubMed ID: 18477594
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
Noe F; Vaghi V; Balducci C; Fitzsimons H; Bland R; Zardoni D; Sperk G; Carli M; During MJ; Vezzani A
Gene Ther; 2010 May; 17(5):643-52. PubMed ID: 20220782
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.
Sørensen AT; Nikitidou L; Ledri M; Lin EJ; During MJ; Kanter-Schlifke I; Kokaia M
Exp Neurol; 2009 Feb; 215(2):328-33. PubMed ID: 19038255
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.
Powell KL; Fitzgerald X; Shallue C; Jovanovska V; Klugmann M; Von Jonquieres G; O'Brien TJ; Morris MJ
Neurobiol Dis; 2018 May; 113():23-32. PubMed ID: 29414380
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy in epilepsy.
Riban V; Fitzsimons HL; During MJ
Epilepsia; 2009 Jan; 50(1):24-32. PubMed ID: 18717707
[TBL] [Abstract][Full Text] [Related]
9. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.
Foti S; Haberman RP; Samulski RJ; McCown TJ
Gene Ther; 2007 Nov; 14(21):1534-6. PubMed ID: 17713567
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures.
Melin E; Andersson M; Gøtzsche CR; Wickham J; Huang Y; Szczygiel JA; Boender A; Christiansen SH; Pinborg L; Woldbye DPD; Kokaia M
Gene Ther; 2023 Aug; 30(7-8):649-658. PubMed ID: 37029201
[TBL] [Abstract][Full Text] [Related]
11. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.
Ledri LN; Melin E; Christiansen SH; Gøtzsche CR; Cifra A; Woldbye DP; Kokaia M
Neurobiol Dis; 2016 Feb; 86():52-61. PubMed ID: 26607785
[TBL] [Abstract][Full Text] [Related]
12. A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line.
Patrício MI; Barnard AR; Green AL; During MJ; Sen A; MacLaren RE
Seizure; 2018 Feb; 55():25-29. PubMed ID: 29367144
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated viral vector-induced overexpression of neuropeptide Y Y2 receptors in the hippocampus suppresses seizures.
Woldbye DP; Angehagen M; Gøtzsche CR; Elbrønd-Bek H; Sørensen AT; Christiansen SH; Olesen MV; Nikitidou L; Hansen TV; Kanter-Schlifke I; Kokaia M
Brain; 2010 Sep; 133(9):2778-88. PubMed ID: 20688813
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for epilepsy.
Simonato M
Epilepsy Behav; 2014 Sep; 38():125-30. PubMed ID: 24100249
[TBL] [Abstract][Full Text] [Related]
15. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum.
Sørensen AT; Kanter-Schlifke I; Lin EJ; During MJ; Kokaia M
Mol Cell Neurosci; 2008 Oct; 39(2):229-37. PubMed ID: 18652899
[TBL] [Abstract][Full Text] [Related]
17. NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.
Sørensen AT; Kanter-Schlifke I; Carli M; Balducci C; Noe F; During MJ; Vezzani A; Kokaia M
Hippocampus; 2008; 18(6):564-74. PubMed ID: 18306304
[TBL] [Abstract][Full Text] [Related]
18. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.
Lin EJ; Richichi C; Young D; Baer K; Vezzani A; During MJ
Eur J Neurosci; 2003 Oct; 18(7):2087-92. PubMed ID: 14622242
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y delays hippocampal kindling in the rat.
Reibel S; Benmaamar R; Lê BT; Larmet Y; Kalra SP; Marescaux C; Depaulis A
Hippocampus; 2003; 13(5):557-60. PubMed ID: 12921346
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
